Showing results (31-40 of 139) with videos related to

Sort By:
Pageof 14
Clinical Pharmacology and Therapeutics|February 1, 2021
Physiologically-Based Pharmacokinetic Modeling Combined with Swiss HIV Cohort Study Data Supports No Dose Adjustment of Bictegravir in Elderly Individuals Living With HIVFelix Stader, Perrine Courlet, Laurent A Decosterd, et al.
Clinical Pharmacokinetics|September 8, 2016
Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions with Efavirenz Involving Simultaneous Inducing and Inhibitory Effects on CytochromesCatia Marzolini, Rajith Rajoli, Manuel Battegay, et al.
British Journal of Clinical Pharmacology|April 13, 2023
Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazoleDavid Haefliger, Catia Marzolini, Frederic Lamoth, et al.
Clinical Pharmacokinetics|April 8, 2021
Pharmacokinetics and Drug-Drug Interactions of Long-Acting Intramuscular Cabotegravir and RilpivirineDaryl Hodge, David J Back, Sara Gibbons, et al.
Expert Review of Clinical Pharmacology|October 16, 2025
Therapeutic drug monitoring of Janus kinase inhibitors for precision dosing: where do we stand ?Jérémie Tachet, Catia Marzolini, Laurent A Decosterd, et al.
Clinical Pharmacokinetics|July 23, 2020
Drug-Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?Vera E Bukkems, Angela Colbers, Catia Marzolini, et al.
Clinical Pharmacokinetics|August 22, 2018
Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent ChangesFelix Stader, Marco Siccardi, Manuel Battegay, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 6, 2026
Therapeutic drug monitoring of letermovir in allogeneic hematopoietic cell transplant recipients: where are we?Dela Wordi, Hong-Tham Nguyen, Françoise Livio, et al.
Clinical Pharmacokinetics|October 5, 2019
Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the ElderlyFelix Stader, Hannah Kinvig, Melissa A Penny, et al.
Antiviral Therapy|April 15, 2025
Sustained viral suppression with once daily dolutegravir-containing regimen in presence of the strong inducer carbamazepineMicol Pallanza, Paul Thoueille, Myriam Briki, et al.
Pageof 14